Top Pharma Taps ArisGlobal for its Advance Intake – a System Agnostic and Modular Generative AI Solution – to Streamline Case Management 

Boston, Massachusetts, USA – July 1, 2025 – ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced that a Top 25 global pharmaceutical company has selected LifeSphere® NavaX™, marking the seventh organization to adopt NavaX in the past 12 months. The organization will leverage NavaX to drive efficiencies in case intake and pharmacovigilance operations, further signaling the industry-wide momentum toward GenAI-powered automation.  

The company currently processes 300,000 safety cases globally each year and will deploy NavaX specifically for case intake operations in Japan. This implementation will introduce a major technical advancement: LifeSphere NavaX’s ability to accurately process case data in native Japanese language and character sets, including both digitally generated content and handwritten medical records. 

By leveraging NavaX’s advanced capabilities—including Dynamic Data Extraction and intelligent language recognition—the organization aims to streamline its Japanese intake workflows while maintaining accuracy and regulatory alignment. These innovations allow pharmacovigilance teams to reduce manual effort, accelerate processing timelines, and improve overall data quality, even when working with complex, non-English documentation. 

The decision to implement NavaX also reflects a broader strategic push to scale AI-led innovation across regions, languages, and formats—supporting global harmonization while adapting to local requirements. 

“The addition of native-language case intake, including handwritten record parsing, is a game changer for automation in Japan’s pharmacovigilance landscape,” said Steve Nuckols, Chief Customer Officer at ArisGlobal. “This seventh global pharma adoption is further proof that leading life sciences organizations are scaling GenAI across geographies. It’s a proud moment to see ArisGlobal’s expanding leadership not only in the APAC region, but enabling global progress through practical, production-ready solutions.” 

This milestone adds to the growing adoption of LifeSphere NavaX as the industry’s leading AI engine of choice. Most recently ArisGlobal announced a Top 10 pharmaceutical company leveraging NavaX, experiencing high accuracy in data extraction for case processing within the first two weeks of implementation. ArisGlobal continues to deliver the tools needed to modernize operations, reduce burden, and unlock real-time insights—on a global scale. 

Share on LinkedIn

Related Posts

Discover NavaX

the latest automation from LifeSphere